Cybin to present at the td cowen 44th annual health care conference

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will present at the td cowen 44th annual health care conference, taking place march 4-6, 2024 in boston, ma. mr. drysdale's presentation will be webcast.
CYBN Ratings Summary
CYBN Quant Ranking